Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03899467
Title the Safety and Tolerability of Proxalutamide (GT0918) in Subjects With Metastatic Castrate Resistant Prostate Cancer
Recruitment Completed
Gender male
Phase Phase II
Variant Requirements No
Sponsors Suzhou Kintor Pharmaceutical Inc,
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
University Cancer & Blood Center Athens Georgia 30607 United States Details
Norton Cancer Institute Louisville Kentucky 40202 United States Details
Chesapeake Urology Research Associates Towson Maryland 21204 United States Details
G U Research Network Omaha Nebraska 68130 United States Details
Comprehensive Cancer Centers of Nevada Las Vegas Nevada 89169 United States Details
New York Cancer & Blood Specialists Bronx New York 10469 United States Details
New York Cancer & Blood Specialists East Setauket New York 11733 United States Details
Gabrail Cancer Center Research Canton Ohio 44718 United States Details
Greenville Health System Greenville South Carolina 29605 United States Details
Mary Crowley Cancer Research Dallas Texas 75230 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field